Orgenesis Inc. (NASDAQ:ORGS – Get Free Report) shares traded down 3.3% during mid-day trading on Wednesday . The company traded as low as $0.50 and last traded at $0.50. 34,800 shares traded hands during trading, a decline of 84% from the average session volume of 218,907 shares. The stock had previously closed at $0.52.
Orgenesis Price Performance
The firm has a market cap of $17.42 million, a PE ratio of -0.56 and a beta of 1.07. The company has a current ratio of 0.25, a quick ratio of 0.25 and a debt-to-equity ratio of 1.48. The business has a fifty day moving average of $0.65 and a 200-day moving average of $0.57.
About Orgenesis
Orgenesis Inc, a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network.
Further Reading
- Five stocks we like better than Orgenesis
- What Does a Stock Split Mean?
- 3 Stocks Leading the U.S. Agriculture Comeback
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- How to Use Put Debit Spreads to Profit From Falling Stocks
- 5 Top Rated Dividend Stocks to Consider
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Orgenesis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orgenesis and related companies with MarketBeat.com's FREE daily email newsletter.
